FTC Orders Greater HSR Reporting of Patent Licenses in the Pharmaceutical Sector

November 11, 2013

One item on the negotiation checklist for patent licenses in the pharmaceutical sector is compliance with the U.S. Hart-Scott-Rodino (“HSR”) Premerger Notification Rules. The HSR rules require that certain patent licenses be reported to the Federal Trade Commission (“FTC”) before implementation. Up until now, the majority of such licenses were not subject to reporting requirements. Changes made by the FTC, taking effect in December, will require greater reporting of pharmaceutical patent licenses.

Read "FTC Orders Greater HSR Reporting of Patent Licenses in the Pharmaceutical Sector."